Profound Medical (PROF) Cost of Revenue (2019 - 2026)

Profound Medical has reported Cost of Revenue for 8 years, with the latest figure at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 95.96% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 41.79% YoY), and the FY2025 full-year result was $4.7 million, up 29.15% from the prior year.
• Cost of Revenue for Q1 2026 stood at $1.5 million, down from $2.0 million in the prior quarter.
• The five-year high for Cost of Revenue was $2.0 million in Q4 2025, with the low at $552000.0 in Q2 2023.
• Average Cost of Revenue over 5 years is $964705.9, with a median of $928000.0 recorded in 2022.
• Year-over-year, Cost of Revenue jumped 102.18% in 2022 and tumbled 49.31% in 2023.
• Tracing PROF's Cost of Revenue over 5 years: stood at $698000.0 in 2022, then jumped by 46.13% to $1.0 million in 2023, then increased by 19.02% to $1.2 million in 2024, then surged by 63.59% to $2.0 million in 2025, then retreated by 24.22% to $1.5 million in 2026.
• The last three Cost of Revenue figures came in at $1.5 million (Q1 2026), $2.0 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.

Peer Comparison